|
ANKRD26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.79110015286722E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5000002895913E-11 |
| Normal-vs-Stage2 |
1.51970000028534E-07 |
| Normal-vs-Stage3 |
2.23243645791626E-12 |
| Normal-vs-Stage4 |
5.92760285300642E-11 |
| Stage1-vs-Stage2 |
6.275600E-01 |
| Stage1-vs-Stage3 |
5.612200E-02 |
| Stage1-vs-Stage4 |
1.358110E-02 |
| Stage2-vs-Stage3 |
3.690400E-01 |
| Stage2-vs-Stage4 |
1.824790E-01 |
| Stage3-vs-Stage4 |
5.979800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34225963677181E-13 |
| Normal-vs-AfricanAmerican |
1.403260E-04 |
| Normal-vs-Asian |
2.54980000446992E-08 |
| Caucasian-vs-AfricanAmerican |
6.309600E-01 |
| Caucasian-vs-Asian |
8.266800E-01 |
| AfricanAmerican-vs-Asian |
5.324000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.33169977454418E-10 |
| Normal-vs-Female |
1.71651581837295E-12 |
| Male-vs-Female |
4.429400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.25820021068535E-10 |
| Normal-vs-Age(41-60Yrs) |
1.53543844305659E-13 |
| Normal-vs-Age(61-80Yrs) |
4.71859995521129E-09 |
| Normal-vs-Age(81-100Yrs) |
1.981370E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.851580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.122400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.348760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.648800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.767800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.048800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.246580E-01 |
| Classical-VS-Follicular |
8.062200E-01 |
| Classical-VS-Other |
6.639000E-01 |
| Classical-VS-Normal |
2.03829999545491E-08 |
| Tall-VS-Follicular |
2.072400E-01 |
| Tall-VS-Other |
6.991000E-01 |
| Tall-VS-Normal |
6.11429995522883E-09 |
| Follicular-VS-Other |
7.872000E-01 |
| Follicular-VS-Normal |
7.787800004877E-08 |
| Other-VS-Normal |
7.337100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.05928632321684E-13 |
| Normal-vs-N1 |
1.39010000177464E-08 |
| N0-vs-N1 |
7.768400E-01 |
|
|
